Riverstone Advisors’s Eli Lilly LLY Stock Holding History

Riverstone Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$485K	Buy	404 +114	+39%	+$116K	0.2%	46
2026 Q1	$267K	Buy	+290	New	+$294K	0.13%	59
2025 Q3	–	Sell	-800	Closed	-$624K	–	64
2025 Q2	$624K	Sell	800 -155	-16%	-$120K	0.34%	28
2025 Q1	$789K	Sell	955 -400	-30%	-$333K	0.47%	23
2024 Q4	$1.05M	Buy	1,355 +5	+0.4%	+$4.14K	0.6%	22
2024 Q3	$1.2M	Hold	1,350	–	–	0.7%	21
2024 Q2	$1.22M	Hold	1,350	–	–	0.75%	21
2024 Q1	$1.05M	Hold	1,350	–	–	0.63%	23
2023 Q4	$787K	Hold	1,350	–	–	0.51%	26
2023 Q3	$725K	Hold	1,350	–	–	0.5%	25
2023 Q2	$633K	Hold	1,350	–	–	0.38%	30
2023 Q1	$464K	Hold	1,350	–	–	0.3%	34
2022 Q4	$494K	Hold	1,350	–	–	0.34%	30
2022 Q3	$437K	Hold	1,350	–	–	0.28%	34
2022 Q2	$438K	Hold	1,350	–	–	0.28%	34
2022 Q1	$387K	Hold	1,350	–	–	0.2%	33
2021 Q4	$373K	Hold	1,350	–	–	0.16%	34
2021 Q3	$312K	Hold	1,350	–	–	0.14%	31
2021 Q2	$310K	Hold	1,350	–	–	0.15%	31
2021 Q1	$252K	Hold	1,350	–	–	0.13%	34
2020 Q4	$228K	Sell	1,350 -74	-5%	-$11K	0.13%	34
2020 Q3	$211K	Hold	1,424	–	–	0.14%	34
2020 Q2	$234K	Buy	+1,424	New	+$219K	0.17%	34

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Riverstone Advisors's LLY Position: Q2 2026 in Review

Riverstone Advisors increased its Eli Lilly (LLY) stake by 39% in Q2 2026, buying an estimated $116K and bringing the position to 404 shares worth $485K. The position accounts for 0.2% of the portfolio, ranked #46.

Riverstone Advisors first reported a position in LLY in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.22M in Q2 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Riverstone Advisors held 404 shares of Eli Lilly worth $485K as of Q2 2026.
Riverstone Advisors bought 114 Eli Lilly shares in Q2 2026, an estimated $116K.
Eli Lilly made up 0.2% of Riverstone Advisors's portfolio in Q2 2026, its #46 holding.
Riverstone Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 23 quarters since.
Riverstone Advisors's Eli Lilly position peaked at $1.22M in Q2 2024.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Riverstone Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.